{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:59Z","timestamp":1760188499060},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1987,5,1]],"date-time":"1987-05-01T00:00:00Z","timestamp":546825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1987,5]]},"DOI":"10.1007\/bf01712834","type":"journal-article","created":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T19:03:12Z","timestamp":1118516592000},"page":"437-444","source":"Crossref","is-referenced-by-count":8,"title":["Dexamethasone-suppressible hyperaldosteronism: Pathophysiology, clinical aspects, and new insights into the pathogenesis"],"prefix":"10.1007","volume":"65","author":[{"given":"F.","family":"Fallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Armanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mantero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G.","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Kuhnle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01712834_CR1","unstructured":"Arteaga E, Kater CE, Biglieri EG (1986) Aldosterone production during prolonged ACTH administration. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 79\u201387"},{"key":"BF01712834_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004872-198308000-00014","volume":"1","author":"C Beretta-Piccoli","year":"1983","unstructured":"Beretta-Piccoli C, Davies DL, Brown JJ, Ferris B, Fraser R, Lever AF, Morton JJ, Robertson JS, Semple PF, Watt RR (1983) Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. J Hypertens 1:197\u2013205","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"BF01712834_CR3","first-page":"I195","volume":"27","author":"EG Biglieri","year":"1970","unstructured":"Biglieri EG, Schambelan M, Slaton PE, Stockigt JR (1970) The intercurrent hypertension in primary aldosteronism. Circ Res 27 [Suppl 1]:I195-I202","journal-title":"Circ Res"},{"key":"BF01712834_CR4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","volume":"74","author":"E Bravo","year":"1983","unstructured":"Bravo E, Tarazi R, Dustan H, Fouad FM, Textor SC, Gifford RW, Vidt DG (1983) The changing clinical spectrum of primary aldosteronism. Am J Med 74:641\u2013651","journal-title":"Am J Med"},{"key":"BF01712834_CR5","first-page":"405","volume-title":"The adrenal gland and hypertension","author":"JMC Connell","year":"1985","unstructured":"Connell JMC, Brown JJ, Lever AF, Davies DL, Fraser R, Robertson JIS (1985) Glucocorticoid-suppressible hyperaldosteronism: steroid and body electrolyte measurements and responses to angiotensin II and adrenocorticotrophin. In: Mantero F, Biglieri EG, Funder JW, Scoggins BA (eds) The adrenal gland and hypertension. Raven Press, New York, pp 405\u2013420"},{"key":"BF01712834_CR6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.8.8.669","volume":"8","author":"JMC Connell","year":"1986","unstructured":"Connell JMC, Kenyon CJ, Corrie JET, Fraser R, Watt R, Lever AF (1986) Dexamethasone-suppressible hyperaldosteronism: adrenal transition cell hyperplasia? Hypertension 8:669\u2013676","journal-title":"Hypertension"},{"key":"BF01712834_CR7","unstructured":"DiMartino J, Stoner E, New MI (1985) Isolation of an immunoreactive substance in patients with dexamethasone-suppressible hyperaldosteronism (DSH). (Abstract). Ped Res 19:185A\/445"},{"key":"BF01712834_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2265.1985.tb00168.x","volume":"22","author":"F Fallo","year":"1985","unstructured":"Fallo F, Sonino N, Armanini D, Luzzi T, Pedini F, Pasini C, Mantero F (1985) A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II. Clin Endocrinol 22:777\u2013785","journal-title":"Clin Endocrinol"},{"key":"BF01712834_CR9","unstructured":"Fallo F, Boscaro M, Sonino N, Mantero F (1986) Abnormal adrenal responsiveness in dexamethasone-suppressible hyperaldosteronism: further evidence. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 105\u2013117"},{"key":"BF01712834_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.1987.tb00772.x","volume":"26","author":"F Fallo","year":"1987","unstructured":"Fallo F, Boscaro M, Sonino N, Mantero F (1987) Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism. Clin Endocrinol 26:163\u2013168","journal-title":"Clin Endocrinol"},{"key":"BF01712834_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-8703(78)90370-8","volume":"95","author":"JB Ferris","year":"1978","unstructured":"Ferris JB, Beevers DG, Brown JJ (1978) Clinical, biochemical and pathological features of low-renin (primary) hyperaldosteronism. Am Heart J 95:375\u2013388","journal-title":"Am Heart J"},{"key":"BF01712834_CR12","first-page":"395","volume-title":"The adrenal gland and hypertension","author":"A Ganguly","year":"1985","unstructured":"Ganguly A (1985) Is glucocorticoid-suppressible hyperaldosteronism mediated by ACTH? In: Mantero F, Biglieri EG, Funder JW, Scoggins BA (eds) The adrenal gland and hypertension. Raven Press, New York, pp 395\u2013404"},{"key":"BF01712834_CR13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.1981.155","volume":"30","author":"A Ganguly","year":"1981","unstructured":"Ganguly A, Weinberger MH (1981) Triamterene-thiazide combination: alternative therapy for primary aldosteronism. Clin Pharmacol Ther 30:246\u2013250","journal-title":"Clin Pharmacol Ther"},{"key":"BF01712834_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jcem-37-5-765","volume":"37","author":"A Ganguly","year":"1973","unstructured":"Ganguly A, Melada GA, Luetscher JA, Dowdy AJ (1973) Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 37:765\u2013775","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jcem-53-5-1040","volume":"53","author":"A Ganguly","year":"1981","unstructured":"Ganguly A, Grim CE, Bergstein J, Brown RD, Weinberger MH (1981) Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations. J Clin Endocrinol Metab 53:1041\u20131046","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM198110223051706","volume":"305","author":"A Ganguly","year":"1981","unstructured":"Ganguly A, Grim CE, Weinberger MH (1981) Anomalous postural response in glucocorticoid-suppressible hyperaldosteronism. N Engl J Med 305:991\u2013993","journal-title":"N Engl J Med"},{"key":"BF01712834_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/jcem-57-2-388","volume":"57","author":"A Ganguly","year":"1983","unstructured":"Ganguly A, Pratt H, Weinberger MH, Grim CE, Fineberg NS (1983) Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of primary aldosteronism. J Clin Endocrinol Metab 57:388\u2013392","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/01.HYP.6.4.563","volume":"6","author":"A Ganguly","year":"1984","unstructured":"Ganguly A, Weinberger MH, Guthrie GP, Fineberg NS (1984) Adrenal steroid response to ACTH in glucocorticoid-suppressible hyperaldosteronism. Hypertension 6:563\u2013567","journal-title":"Hypertension"},{"key":"BF01712834_CR19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/jcem-36-4-715","volume":"36","author":"GS Giebink","year":"1973","unstructured":"Giebink GS, Gotlin RW, Biglieri EG, Katz FH (1973) A kindred with familial glucocorticoid-suppressible hyperaldosteronism. J Clin Endocrinol Metab 36:715\u2013723","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/jcem-53-2-331","volume":"53","author":"JR Gill","year":"1981","unstructured":"Gill JR, Bartter FC (1981) Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism. J Clin Endocrinol Metab 53:331\u2013337","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jcem-59-5-1022","volume":"59","author":"CE Gomez-Sanchez","year":"1984","unstructured":"Gomez-Sanchez CE, Montgomery M, Ganguly A, Holland OB, Gomez-Sanchez EP, Grim CE, Weinberger MH (1984) Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 59:1022\u20131024","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/endo-115-2-462","volume":"115","author":"EP Gomez-Sanchez","year":"1984","unstructured":"Gomez-Sanchez EP, Gomez-Sanchez CE, Smith JS, Ferriss MW, Foecking MW (1984) Receptor binding and biological activity of 18-hydroxycortisol. Endocrinology 115:462\u2013466","journal-title":"Endocrinology"},{"key":"BF01712834_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/endo-116-1-6","volume":"116","author":"CE Gomez-Sanchez","year":"1985","unstructured":"Gomez-Sanchez CE, Gomez-Sanchez EP, Smith JS, Ferriss MW, Foecking MW (1985) Receptor binding and biologic activity of 18-oxocortisol. Endocrinology 116:6\u201310","journal-title":"Endocrinology"},{"key":"BF01712834_CR24","unstructured":"Gomez-Sanchez CE, Gill JR, Ganguly A, Gordon RD (1986) Glucocorticoid-suppressible aldosteronism: a disorder of the transitional zone? In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 41\u201348"},{"key":"BF01712834_CR25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1542\/peds.65.3.597","volume":"65","author":"CE Grim","year":"1980","unstructured":"Grim CE, Weinberger MH (1980) Familial dexamethasone-suppressible normokalemic hyperaldosteronism. Pediatrics 65:597\u2013604","journal-title":"Pediatrics"},{"key":"BF01712834_CR26","unstructured":"Grim CE, Ganguly A, Weinberger MH (1986) A rapid method to differentiate glucocorticoid-suppressible hyperaldosteronism from other causes of primary aldosteronism with an anomalous postural response of plasma aldosterone. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 69\u201378"},{"key":"BF01712834_CR27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jcem-56-4-853","volume":"59","author":"HG G\u00fcllner","year":"1983","unstructured":"G\u00fcllner HG, Nicholson WE, Gill JR, Orth DN (1983) Plasma immunoreactive proopiomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism. J Clin Endocrinol Metab 59:853\u2013855","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.HYP.8.4.317","volume":"8","author":"CE Hall","year":"1986","unstructured":"Hall CE, Gomez-Sanchez CE (1986) Hypertensive potency of 18-oxocortisol in the rat. Hypertension 8:317\u2013322","journal-title":"Hypertension"},{"key":"BF01712834_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-5-1-1","volume":"5","author":"ME Keller-Wood","year":"1984","unstructured":"Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1\u201324","journal-title":"Endocr Rev"},{"issue":"Suppl 274","key":"BF01712834_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/acta.0.111S179","volume":"111","author":"U Kuhnle","year":"1986","unstructured":"Kuhnle U, Armanini D, Fallo F, Wehling M, D\u00f6rr H, Sonino N, Mantero F (1986) Plasma mineralocorticoid activity, mineralocorticoid receptors and intracellular electrolytes in patients with dexamethasone-suppressible hyperaldosteronism (DSH). (Abstract). Acta Endocrinol 111 [Suppl 274]:179\u2013180","journal-title":"(Abstract). Acta Endocrinol"},{"key":"BF01712834_CR31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jcem-62-5-934","volume":"62","author":"U Kuhnle","year":"1986","unstructured":"Kuhnle U, Land M, Ulick S (1986) Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia. J Clin Endocrinol Metab 62:934\u2013940","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR32","unstructured":"Laidlaw JC (1986) Dexamethasone-suppressible hyperaldosteronism: patients JS and LS twenty years later. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 133\u2013137"},{"key":"BF01712834_CR33","first-page":"165","volume-title":"Hypertension in children and adolescents","author":"NC Lan","year":"1981","unstructured":"Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Baxter J (1981) Role of steroids in various states of mineralocorticoid excess hypertension: analysis by mineralocorticoid receptor assay. In: Giovannelli G, New MI, Gorini S (eds) Hypertension in children and adolescents. Raven Press, New York, pp 165\u2013175"},{"key":"BF01712834_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/acta.0.0990251","volume":"99","author":"SM Lee","year":"1982","unstructured":"Lee SM, Lightner E, Witte M, Oberfield SE, Levine LS, New MI (1982) Dexamethasone-suppressible hyperaldosteronism in a child with nephrosclerosis. Acta Endocrinol 99:251\u2013255","journal-title":"Acta Endocrinol"},{"key":"BF01712834_CR35","first-page":"329s","volume":"51","author":"F Mantero","year":"1976","unstructured":"Mantero F, Gion M, Armanini D, Opocher G (1976) Aldosterone regulation in primary aldosteronism: differences between adenoma and hyperplasia. Clin Sci Mol Med 51:329s-332s","journal-title":"Clin Sci Mol Med"},{"key":"BF01712834_CR36","doi-asserted-by":"crossref","first-page":"289s","DOI":"10.1042\/cs061289s","volume":"61","author":"F Mantero","year":"1981","unstructured":"Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C (1981) Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci 61:289s-293s","journal-title":"Clin Sci"},{"key":"BF01712834_CR37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jcem-28-12-1807","volume":"28","author":"K Miura","year":"1968","unstructured":"Miura K, Ioshinaga K, Goto K, Katsushima K, Maebashi M, Demura H, Iino M, Demura R, Torikai T (1968) A case of glucocorticoid-responsive hyperaldosteronism. J Clin Endocrinol Metab 28:1807\u20131815","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR38","unstructured":"Miura K, Yamakita N, Yasuda K, Murase H, Takeda N, Takeuchi K, Yasujima H, Murakami O, Abe K, Yoshinaga K, Sasano N (1986) Clinical features of dexamethasone-suppressible hyperaldosteronism in Japan with study in our case followed for 18 years. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 89\u2013104"},{"key":"BF01712834_CR39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1536\/ihj.25.379","volume":"25","author":"K Mizuno","year":"1984","unstructured":"Mizuno K, Haruyama K, Gotoh M, Matsui J, Fukuchi S (1984) Evidence for the role of kinins in the acute antihypertensive effect of captopril in low-renin hypertension. Jpn Heart J 25:379\u2013386","journal-title":"Jpn Heart J"},{"key":"BF01712834_CR40","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198110223051712","volume":"305","author":"PJ Mulrow","year":"1981","unstructured":"Mulrow PJ (1981) Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone? N Engl J Med 305:1012\u20131014","journal-title":"N Engl J Med"},{"key":"BF01712834_CR41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/jcem-37-1-93","volume":"37","author":"MI New","year":"1973","unstructured":"New MI, Siegal EJ, Peterson RE (1973) Dexamethasone-suppressible hyperaldosteronism. J Clin Endocrinol Metab 37:93\u2013100","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR42","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1210\/jcem-43-6-1283","volume":"43","author":"MI New","year":"1976","unstructured":"New MI, Peterson RE, Saenger P, Levine LS (1976) Evidence for an unidentified ACTH-induced steroid causing hypertension. J Clin Endocrinol Metab 43:1283\u20131293","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(80)92814-7","volume":"I","author":"MI New","year":"1980","unstructured":"New MI, Oberfield SE, Levine LS, Dupont B, Pollack M, Gill JR, Bartter FC (1980) Autosomal dominant transmission and absence of HLA linkage in dexamethasone-suppressible hyperaldosteronism. Lancet I:550\u2013551","journal-title":"Lancet"},{"key":"BF01712834_CR44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1210\/jcem-53-1-158","volume":"53","author":"SE Oberfield","year":"1981","unstructured":"Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee MS, Lightner E, Witte M, New MI (1981) Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism. J Clin Endocrinol Metab 53:158\u2013164","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"BF01712834_CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01477468","volume":"56","author":"W Rauh","year":"1978","unstructured":"Rauh W, Levine LS, Gottesdiener K, New MI (1978) Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension. Klin Wochenschr 56 [Suppl 1]:161\u2013168","journal-title":"Klin Wochenschr"},{"issue":"Suppl 1","key":"BF01712834_CR46","first-page":"177","volume":"8","author":"S Rocco","year":"1985","unstructured":"Rocco S, Fallo F, Luzzi T, Opocher G, Mantero F (1985) Diagnostic relevance of acute converting enzyme blockade in differentiating idiopathic hyperaldosteronism (IHA) from aldosterone-producing adenoma (APA). (Abstract). J Endocrinol Invest 8 [Suppl 1]:177","journal-title":"(Abstract). J Endocrinol Invest"},{"key":"BF01712834_CR47","first-page":"326","volume-title":"Hypertension '72","author":"JL Ruse","year":"1972","unstructured":"Ruse JL, Price C, Stiefel M, Laidlaw JC (1972) The influence of glucocorticoids and heparin on aldosterone production. In: Genest J, Koiw E (eds) Hypertension '72, Springer, Berlin, pp 326\u2013336"},{"key":"BF01712834_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jcem-43-1-115","volume":"43","author":"M Schambelan","year":"1976","unstructured":"Schambelan M, Brust NL, Chang BCF, Slater KL, Biglieri EG (1976) Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 43:115\u2013131","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/acta.0.0980087","volume":"98","author":"N Sonino","year":"1981","unstructured":"Sonino N, Levine LS, New MI (1981) Mineralocorticoid and metabolic response to metyrapone in normotensive children and children with dexamethasone-suppressible and primary aldosteronism. Acta Endocrinol 98:87\u201394","journal-title":"Acta Endocrinol"},{"key":"BF01712834_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/jcem-61-2-297","volume":"61","author":"PW Speiser","year":"1985","unstructured":"Speiser PW, Martin KO, Kao-Lo G, New MI (1985) Excess mineralocorticoid receptor activity in patients with dexamethasone-suppressible hyperaldosteronism is under adrenocorticotropin control. J Clin Endocrinol Metab 61:297\u2013302","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR51","unstructured":"Stockigt JR, Scoggins BA (1986) Evolution of dexamethasone-suppressible to idiopathic hyperaldosteronism. In: New MI, Borrelli P (eds) Dexamethasone-suppressible hyperaldosteronism, Serono symposia review no. 10, Rome, pp 119\u2013132"},{"key":"BF01712834_CR52","first-page":"1109","volume":"95","author":"DJA Sutherland","year":"1966","unstructured":"Sutherland DJA, Ruse JL, Laidlaw (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Ass J 95:1109\u20131119","journal-title":"Can Med Ass J"},{"key":"BF01712834_CR53","first-page":"1771","volume":"A4","author":"S Ulick","year":"1982","unstructured":"Ulick S, Chu M (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens A4:1771\u20131777","journal-title":"Clin Exp Hypertens"},{"key":"BF01712834_CR54","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1210\/endo-113-6-2320","volume":"113","author":"S Ulick","year":"1983","unstructured":"Ulick S, Land M, Chu M (1983) 18-Oxocortisol, a naturally occurring mineralocorticoid agonist. Endocrinology 113:2320\u20132322","journal-title":"Endocrinology"},{"key":"BF01712834_CR55","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/S0021-9258(20)81918-8","volume":"258","author":"S Ulick","year":"1983","unstructured":"Ulick S, Chu M, Land M (1983) Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J Biol Chem 258:5498\u20135502","journal-title":"J Biol Chem"},{"key":"BF01712834_CR56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","volume":"90","author":"MH Weinberger","year":"1979","unstructured":"Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP (1979) Primary aldosteronism: diagnosis, localization, treatment. Ann Int Med 90:386\u2013395","journal-title":"Ann Int Med"},{"key":"BF01712834_CR57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jcem-52-2-195","volume":"52","author":"M Wisgerhof","year":"1981","unstructured":"Wisgerhof M, Brown RD, Mogen MJ, Carpenter PC, Edis AJ (1981) The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and in idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195\u2013198","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01712834_CR58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1440-1681.1985.tb02640.x","volume":"12","author":"E Woodland","year":"1985","unstructured":"Woodland E, Tunny TJ, Hamlet SM, Gordon RD (1985) Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-supressible hyperaldosteronism. Clin Exp Pharmacol Physiol 12:245\u2013248","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712834.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01712834\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:19:02Z","timestamp":1683109142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01712834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,5]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1987,5]]}},"alternative-id":["BF01712834"],"URL":"https:\/\/doi.org\/10.1007\/bf01712834","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,5]]}}}